Co-Authors
This is a "connection" page, showing publications co-authored by BINGLIANG FANG and DON LYNN GIBBONS.
Connection Strength
0.341
-
KRT-232 and navitoclax enhance trametinib's anti-Cancer activity in non-small cell lung cancer patient-derived xenografts with KRAS mutations. Am J Cancer Res. 2020; 10(12):4464-4475.
Score: 0.189
-
Overcoming resistance to anti-PD immunotherapy in a syngeneic mouse lung cancer model using locoregional virotherapy. Oncoimmunology. 2017; 7(1):e1376156.
Score: 0.153